Ashcorp Group is setting a new benchmark for leadership in an era where the value of a corporation is increasingly measured by its contribution to humanity rather than just its fiscal year growth.
By integrating social impact and health equity into the heart of its corporate DNA, Ashcorp Group is proving that sustainable business performance is inextricably linked to the vitality of the communities it inhabits.
For Ashcorp Group, redefining success means ensuring that the dividends of its growth are reflected in the improved quality of life for the underserved and the systematic removal of barriers to quality healthcare.
“Growth should extend beyond business performance to include meaningful contributions to society,” Nneka Onita, corporate communications manager at Ashcorp Group said during the company’s outreach visit to the Sickle Cell Foundation of Nigeria ahead of the World Sickle Cell Awareness Day, observed annually on June 19.
Ashcorp Group is a global luxury fashion, lifestyle, and beauty conglomerate with offices in Nigeria, and the United Kingdom. Founded in 2016 by Yinka Ashogbon, the Group is home to iconic brands such as Ashluxe and Ashluxury and is redefining the meaning of luxury on the world stage.
The company’s visit to the Sickle Cell Foundation of Nigeria focused on engaging directly with the realities of sickle cell disease in Nigeria while supporting ongoing efforts to improve patient care and outcomes.
“Our visit to the Sickle Cell Foundation is part of our commitment to supporting better health outcomes in line with the United Nations Sustainable Development Goal 3, which focuses on good health and well-being,” Onita said.
With a bold vision and an unwavering commitment to innovation, Ashcorp Group continues to shape culture through design, storytelling, and global influence. Its brands serve as a platform for creativity, self-expression, and the evolving aspirations of a new generation.
“During the visit, the Ashcorp team received a briefing from the Foundation’s staff, toured the facility, and spent time with patients and their families to better understand their experiences. As part of the engagement, Ashcorp donated medication and essential supplies to support the Foundation’s work and the needs of patients under its care,” Onita noted.
“Sickle cell disease remains one of the most common genetic conditions globally, with approximately 5 percent of the world’s population carrying the gene for haemoglobin disorders.
“Nigeria bears the highest burden, with an estimated one in four Nigerians identified as carriers and between 100,000 and 150,000 children born annually with the condition. Efforts like this cannot be occasional. They have to be consistent to make a real difference,” she added.
“These figures highlight the importance of sustained awareness, early diagnosis, and access to consistent care. Institutions such as the Sickle Cell Foundation of Nigeria play a critical role in addressing these needs through patient care, education, and family support,” Ashcorp noted.
“As part of the engagement, Ashcorp donated medication and essential supplies to support the Foundation’s work and the needs of patients under its care,” Onita said.
Ashcorp Group noted that this contribution is part of a broader commitment to supporting better health outcomes and engaging with issues that directly affect communities.
The company also acknowledged the resilience of patients and families living with sickle cell disease and reaffirmed its intention to maintain a long-term relationship with the Foundation.
Join BusinessDay whatsapp Channel, to stay up to date
Open In Whatsapp
